Literature DB >> 9140110

Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas.

H Ojima1, T Fukuda, T Nakajima, Y Nagamachi.   

Abstract

Epstein-Barr virus (EBV) infection was studied in a total of 412 patients with poorly differentiated gastric adenocarcinoma by in situ hybridization for EBV-encoded small RNA. EBV-specific RNA was detected in tumor cell nuclei of 83 (20.1%) of 412 gastric carcinomas, of which 60 were histologically subclassified as gastric carcinoma with lymphoid stroma (GCLS). All EBV-positive gastric carcinomas as well as 90 randomly selected EBV-negative gastric carcinomas were further studied for p53 protein expression by immunohistochemistry. The overexpression of p53 protein was demonstrated in only 7 (8.4%) of 83 EBV-positive gastric carcinomas. This was in marked contrast to the frequency of 34.4% in EBV-negative gastric carcinomas. In addition, a few p53-positive nuclei were characteristically scattered in the tumors of many EBV-positive GCLS, but this was not regarded as p53 overexpression arising from mutation of the gene. Our findings suggested that EBV-associated gastric carcinomas may arise through a different mechanism from other types of gastric carcinomas without EBV infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140110      PMCID: PMC5921379          DOI: 10.1111/j.1349-7006.1997.tb00376.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  44 in total

Review 1.  Biochemical properties of the growth suppressor/oncoprotein p53.

Authors:  M Montenarh
Journal:  Oncogene       Date:  1992-09       Impact factor: 9.867

Review 2.  The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas.

Authors:  J C Iezzoni; M J Gaffey; L M Weiss
Journal:  Am J Clin Pathol       Date:  1995-03       Impact factor: 2.493

3.  Epstein-Barr virus and gastric remnant cancer.

Authors:  N Yamamoto; M Tokunaga; Y Uemura; S Tanaka; H Shirahama; T Nakamura; C E Land; E Sato
Journal:  Cancer       Date:  1994-08-01       Impact factor: 6.860

4.  Epstein-Barr virus in gastric carcinoma.

Authors:  M Tokunaga; C E Land; Y Uemura; T Tokudome; S Tanaka; E Sato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

5.  High expression of the Epstein-Barr virus latent protein EB nuclear antigen-2 on pyothorax-associated lymphomas.

Authors:  Y Sasajima; H Yamabe; Y Kobashi; K Hirai; S Mori
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

6.  EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

Authors:  L Szekely; G Selivanova; K P Magnusson; G Klein; K G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

7.  Epstein-Barr virus association with early cancers found together with gastric medullary carcinomas demonstrating lymphoid infiltration.

Authors:  Y Takano; Y Kato
Journal:  J Pathol       Date:  1995-01       Impact factor: 7.996

8.  In situ detection of Epstein-Barr virus in gastric and colorectal adenocarcinomas.

Authors:  S T Yuen; L P Chung; S Y Leung; I S Luk; S Y Chan; J Ho
Journal:  Am J Surg Pathol       Date:  1994-11       Impact factor: 6.394

9.  Epstein-Barr-virus-associated medullary carcinomas with lymphoid infiltration of the stomach.

Authors:  Y Takano; Y Kato; H Sugano
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more
  8 in total

Review 1.  Epstein-Barr virus and gastric carcinoma.

Authors:  K Takada
Journal:  Mol Pathol       Date:  2000-10

2.  Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location.

Authors:  Gwen Murphy; Ruth Pfeiffer; M Constanza Camargo; Charles S Rabkin
Journal:  Gastroenterology       Date:  2009-05-13       Impact factor: 22.682

3.  A case of gastric cancer with heterogeneous components of EB virus (+)/TP53 (+) and EB virus (-)/TP53 (-).

Authors:  Ikuo Matsuda; Kazuomi Kan; Sadayuki Doi; Yoshiyuki Motoki; Masayuki Onodera; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  Epstein-Barr virus and gastric carcinoma--viral carcinogenesis through epigenetic mechanisms.

Authors:  Hiroshi Uozaki; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

5.  LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.

Authors:  Jung-Young Shin; Jeong-Oh Kim; Suk Kyeong Lee; Hiun-Suk Chae; Jin-Hyoung Kang
Journal:  BMC Cancer       Date:  2010-08-13       Impact factor: 4.430

Review 6.  Lymphoepithelioma-like carcinoma of the stomach: a case report and review of the literature.

Authors:  Zeid Bittar; Falko Fend; Leticia Quintanilla-Martinez
Journal:  Diagn Pathol       Date:  2013-11-04       Impact factor: 2.644

7.  Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis.

Authors:  Ahmad Tavakoli; Seyed Hamidreza Monavari; Farid Solaymani Mohammadi; Seyed Jalal Kiani; Saber Armat; Mohammad Farahmand
Journal:  BMC Cancer       Date:  2020-06-01       Impact factor: 4.430

Review 8.  Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.

Authors:  Shuting Han; Joshua K Tay; Celestine Jia Ling Loh; Axel Jun Ming Chu; Joe Poh Sheng Yeong; Chwee Ming Lim; Han Chong Toh
Journal:  Front Immunol       Date:  2021-12-10       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.